Summary A Ha-ras transformant '7-4', derived from mouse NIH/3T3 fibroblasts, was used to study the relationship between overexpression of activated Ha-ras and cell apoptosis. This cell line contains an inducible Ha-rasVa12 oncogene, which was under the regulation of the Escherichia coli (E. coli) lac operator/repressor system. We demonstrate that overexpression of activated Ha-ras oncogene by exogenous isopropyl-o-D-thiogalactoside (IPTG) under serum-depleted conditions can stimulate cell apoptosis. Cell cycle analysis showed that most of the 7-4 cells with Ha-ras overexpression accumulated at S-phase and that the expression level of p34cdC2 kinase was decreased, suggesting that p34cdc2 may be involved in 7-4 cell apoptosis. Overexpression of bcl-2 transgene in these cells blocked Ha-ras-induced apoptosis, and this blockage was confirmed downstream of Ha-ras gene expression. Cycloheximide blocked the apoptosis of 7-4 cells in a dose-dependent manner, indicating that specific protein regulating apoptosis may be synthesized through Ha-ras overexpression. Ha-ras overexpressiontriggered apoptosis was also prevented in the 7-4 derivatives that express either dominant-negative rasAsnl7 or dominant-negative raf-1 C4B to suppress Ha-ras signal transduction at different stages, indicating that overexpression of activated Ha-ras can induce cell apoptosis and that raf-1 pathway activity is required for this process.
Three ras proto-oncogenes (H-, K-and N-ras) in the ras family are found in the mammalian genome (Downward, 1992) . The activated ras oncogenes (such as the viral v-ras oncogenes) that are derived from normal cellular proto-oncogenes and activated by the mutations at amino acid position 12 and several other sites are the most frequently identified oncogenes in human neoplasia, indicating that ras oncogenes play an important role in the process of carcinogenesis (Barbacid, 1987) . Extensive studies have demonstrated that cell proliferation and differentiation are dependent upon Ras. This includes the raf-l product and the mitogen-activated protein (MAP) kinase. In recent studies, several investigators have suggested that the role of activated ras oncogenes in the process of carcinogenesis is to provide cells with not only a selective proliferation function but also an antiapoptotic function (Sakai et al, 1994) . Arends et al (1994) reported that transfectants with moderate or high oncogenic Ha-rasvall2 expression showed reduced apoptosis. Several reports have also suggested that expression of oncogenic ras has the ability to prevent apoptosis and increase cell survival to anti-cancer drugs or ionizing radiation at doses that demonstrate apoptosis (Arends et al, 1993; Sakai et al, 1994; Jimenez et al, 1995) . Conversely, some reports have recently demonstrated that Ha-ras oncogene overexpression could induce apoptosis, which includes promoting the sensitivity of murine fibroblast lOTl/2 cells to apoptosis induced by tumour necrosis factor, inducing apoptosis of Jurkat cells after suppression of protein kinase C (PKC) activity (Chen and Faller, 1996) and triggering apoptosis of REF cells in the presence of the IRF-l gene (Tanaka et al, 1994) . Moreover, it is found that Ha-ras is an effective promoter of apoptosis through the Raf pathway, whereas c-myc was found to be overexpressed under serum-deprived conditions (Kauffmann-Zeh et al, 1997) .
Furthermore, Fas ligation-induced apoptosis in immune homeostasis needs normal ras activation (Gulbins et al, 1995) . In the ras superfamily, overexpression of normal rho-p21 or activated R-Ras induces apoptosis in NIH/3T3 cells after serum deprivation (Jimenez et al, 1995; Wang et al, 1995) . Thus, either normal or activated ras genes from the ras family or the ras superfamily may be involved in apoptosis. The mechanisms of their action may differ from one cell system to another. It is possible that the effects depend on the status of other genes known to regulate apoptosis (such as bcl-2, c-myc and p53) (Femandez et al, 1995) .
In this report, a NIH/3T3 derivative designated 7-4 containing an inducible Ha-rasvalI2 oncogene regulated by an Escherichia coli lac repressor was used to demonstrate that Ha-ras overexpression can indeed trigger apoptosis by manipulating the inducer of isopropyl-p-D-thiogalactoside (IPTG) . This apoptosis was further confirmed by dominant-negative rasAsnl7 and raf-1C4B studies.
MATERIALS AND METHODS Cell culture
Mouse fibroblast NIH/3T3 cells and their transgenic derivatives (7-4, 7-4-2 and dominant-negative ras and raf-l cells) were maintained in a-modified Eagle medium (a-MEM; Gibco-BRL, USA) containing 10% calf serum (Gibco) and incubated at 37°C in a carbon dioxide incubator. The 7-4 cells contain plasmids pSVlacOras and p3'SS (Stratagene, USA) (Liu et al, 1992; Ducoeur et al, 1993) ; and 7-4-2 cells, a derivative of 7-4 cells, contain the third plasmid pCAJ-bcl-2 (Tsujimoto, 1989) . IPTG (Gold biotechnology, USA), a non-metabolizable lactose analogue, was added to induce expression of Ha-ras transgene in 7-4 and 7-4-2 cells. 
Microassay for cell viability
The microassay for cell viability was performed as described previously (Ito, 1984) . Briefly, cells were seeded in the 96-well flat-bottom microplates (Nunc, Denmark) at appropriate concentrations (1-1.5 x 104 cells per 100 gl per well) and incubated at 37°C in a carbon dioxide incubator for 4 h for cell attachment. The medium was then replaced with fresh medium. Eight wells were used for each treatment. At the end of the incubation, the medium was removed and the cells in wells were then fixed with 10% formalin (50 ,l per well) for 10 min, after which they were stained with 0.05% crystal violet (30 gl per well) for 30 min. The stained microplates were rinsed with tap water and then air dried. For the determination of cell viability, colorimetry was used. The elution fluid containing 50% ethanol and 0.1% acetic acid (150 p1 per well) was added to each well, and the eluted blue dye in each well was quantified by optical density measured at 590 nm (OD590) with a Dynatech MR5000 microplate reader (Dynatech laboratories, VA, USA). Northern blot analysis Thirty micrograms of total RNA prepared from the cells was loaded into the wells on a 1% agarose gel containing 5 M glyoxal. The RNA was fractionated by electrophoresis at 80 V, 80 mA, for 2 h, transferred to a Hybond-N transfer membrane in 25 mM sodium phosphate, pH 6.5, and hybridized with the probes labelled with [a-32P]dCTP to a specific activity of 4 x 108 dpm ig-' by random priming (Sambrook et al, 1989) . The blot was exposed to Kodak X-OMAT AR film with the intensifying screen before development (Liu et al, 1992 ETD, 50 mm Tris-HCl, pH 7.5] for 10 s and centrifuged for 5 min at 3100 g twice. The supernatant was brought to 1% SDS with RNAase A (5 ,ug pl-) and kept at 56°C for 2 h followed by digestion with 2.5 gg ul-' proteinase K (Boehringer Mannheim) for at least 2 h at 37°C. After addition of 0.5 vol 10 M ammonium acetate, the DNA was precipitated with 2.5 vols 100% ethanol, resuspended in TE buffer (10 mm Tris-HCl, pH 7.5, 1 mM EDTA) and separated by electrophoresis on a 1% TAE-agarose gel at 30 V for 8 h. The DNA fragments were visualized by ethidium bromide staining (Hermann et al, 1994) .
CAT assay A 50-,ug cell lysate was incubated at 65°C for 10 min to denature the deacetylase activities. Twenty microlitres (3.5 mg ml-') of acetyl coenzyme A (Sigma) and 2 gl (sp. act. = 56 mCi mmol-1) of ['4C]chloramphenicol (Amersham, UK) were added to the lysate and incubated at 37°C for 1 h. To stop the reaction, 1 ml of ethyl acetate (BDH, UK) was added to each sample and 0.9 ml of the upper phase was transferred to the new Eppendorf tube and dried by a speed vac (Eyela, Japan). The pellet was resuspended in 10 tl of ethyl acetate and dotted on the 25-mm thin-layer chromatography silica plate (Merck, Germany). The samples were spread by the chloroform-methanol mixture (95:5) (BDH, UK). The percentage of ['4C]chloramphenol acetylated was quantified by cutting the acetylated and non-acetylated spots and measuring the amount of radioactivity using the scintillation counter (LS 5000 TA, Beckman, USA).
Luciferase and P-galactosidase activities assay The luciferase and P-galactosidase activities were determined by a Dual-Light luciferase and ,B-galactosidase reporter gene assay system (Tropix, USA). Briefly, equivalent amounts of protein lysates (the final volume was 10 pl) were mixed with buffer A, containing the reagents necessary for the luciferase reaction. Light signal from the luciferase enzyme present in the extract was measured immediately by a luminometer (Lumat, LB 9501, Germany) after the addition of buffer B containing luciferin and Galacton-plus. After another 30-min incubation, the light signal from the accumulated product of ,B-galactosidase and Galactonplus reaction is initiated by the addition of a light emission accelerator and measured using the luminometer.
RESULTS
Ha-ras transgene was overexpressed in the transformants in the presence of IPTG under serum-deprived conditions
The Ha-rasval'2 oncogene (GGC to GUC) cloned from the human T24 bladder carcinoma cell line (driven by an SV40 promoter with the E. coli lac repressor-binding operator) was introduced into (Figure 2) .
To clarify whether the death of major 7-4 cells is apoptotic, the cells maintained in 0.2% serum-containing medium with or without IPTIG induction for 48 and 72 h were analysed using DNA fragmentation analysis and acridine orange staining. Evident DNA fragmentation was detected in 7-4 cells maintained in 0.2% serumcontaining medium for 48 and 72 h, while Ha-ras was overexpressed by IPTG induction ( Figure 3B ). IPTG per se or serum deprivation alone without Ha-ras overexpression could not stimulate apoptosis of all the cells tested ( Figure 3A) . Moreover, many 7-4 cells were rounded, and in about 80% of the cells (797 ± 5 / lx103 cells) the chromatin was condensed and heavily stained by Figure 7 Western blotting demonstrates that the decreased levels of p34cdC2 in 7-4 cells was related to serum starvation and Ha-ras overexpression. The cells (1 x 106 per 1 00-mm plate) were starved in 2% serum containing medium for 24 h, IPTG was then added. Total protein lysates were extracted at the time as indicated. An aliquot (50 gg) of the total protein was fractionated on the 12% SDS-polyacrylamide gel, and blotted onto the PVDF membrane. The expression of p34c&2, Cyclin B and Ras were detected by anti-p34cdc2, anti-Cyclin B and anti-Ras antibodies followed by enhanced chemiluminescence detection using anti-mouse IgG acridine orange in the presence of IPTG for 72 h. However, 7-4 cells without IPTG induction showed normal flat morphology with very faint acridine orange staining. Less than 20% of the cells were apoptotic (178 ± 6 / 1 x 103 cells) (Figure 4 ).
Apoptosis of 7-4 cells triggered by Ha-ras overexpression could be prevented by bcl-2 overexpression or cycloheximide treatment
To test whether bcl-2 transgene overexpression could block Haras oncogene-induced apoptosis, the 7-4-2 cells that stably expressed the human bcl-2 gene (driven by an SV40 early promoter) were investigated. The expression of bcl-2 transgene at transcriptional and translational levels in 7-4-2 cells was confirmed (data not shown). DNA fragmentation in 7-4-2 cells could not be detected, suggesting that bcl-2 overexpression could block Ha-ras-induced apoptosis ( Figure 5B, lanes 4-6) . Neither IPTG nor serum starvation was sufficient to induce cell apoptosis without Ha-ras overexpression ( Figure 5A ). Moreover, 7-4-2 cells also showed spindle-like morphology. In contrast, 7-4 cells with significant DNA fragmentation started to contract and become round at 48 h and aggregated together within 72 h ( Figure 5C ).
While protein synthesis inhibitor cycloheximide (CX) was applied to 7-4 cells, Ha-ras-induced apoptosis was delayed in a CX dose-dependent manner, indicating that de novo protein synthesis is required for 7-4 cell apoptosis (Figure 6 Plasmid p5x colITRE-CAT contains five tandem repeats of human collagenase promoter TRE that can be activated by binding to AP-1 (Wang et al, 1994) . pSG51acZ was used as an internal control for transfection efficiency. All the cells were maintained in the medium with 10% calf serum plus 2.5 mm IPTG for 48 h, then the cells were harvested and analysed. CAT activity was presented as the following:
Relative CAT activity = counts in acetylated species (% of conversion) (counts in acetylated species + in non-acetylated species) (B) For colony formation analysis, the cells (5 x 103 per 35-mm plate) were plated into six-well trays and cultured in 0.33% agar containing the medium supplemented with 10% calf serum in the presence of IPTG. Colonies were counted at day 10. (C) For cell growth analysis, cells (1 x 103 per 96 wells) were plated into 96-well trays in the medium with IPTG. The cell number was counted at a 24-h interval for 5 days by the microassay (Ito, 1984) The expression level of kinase p34cdc was decreased while 7-4 cells were grown in serum-deprived conditions accompanied by Ha-ras overexpression To understand the possible factors involved in the aberration of the 7-4 cell cycle and subsequent cell apoptosis, the kinases cyclin A, B and p34d2 regulating the cell cycle from G!GI to M-phase were observed at the translational level. The treatment of the cells is the same as described above. Briefly, cell lysates were extracted at a 24-h interval until 72 h after IPTG induction, and the expression levels of p34cdc2, cyclin A and B were investigated. Figure 7A shows the expression levels of p34cdc2 and cyclin B using western blotting. Evidently, the p34cdc2 protein levels were inversely decreased, whereas the time for IPTG treatment was increased under 0.2% serum-containing medium. Comparatively, the expression levels of cyclin B were unchanged. Similar to cyclin B, the expression level of cyclin A was unchanged as well (data not shown). The falling of p34cdc2 expression either due to Ha-ras overexpression or due to serum deprivation or due to both was determined by administration of IPTG. Figure 7B demonstrates that serum deprivation alone could cause significant falling of p34cdc2 ( Figure 7B, lanes 1, 2 and 4 and Ha-ras overexpression (1.95-to 2.8-fold) further enhanced this suppression by 1.8-to 2-fold ( Figure 7B , lanes 2 and 3, 4 and 5). Moreover, the phosphorylation of p34cdc2 was not affected by Ha-ras overexpression under serum-deprived conditions (unpublished data). The decrease in p34cdc2 at the translational level seems to play an important role in disruption of the cell cycle.
Dominant-negative ras and dominant negative raf-1 blocked Ha-ras overexpression-induced apoptosis at different signal transduction stages To ensure that Ha-ras indeed triggers the apoptosis of 7-4 cells, the dominant negative ras [in plasmid pZIPneoAsn 17 with a mutation at amino acid 17 (serine to asparagin)] was transfected into 7-4 cells to block Ras activity (Feig and Cooper, 1988) . Three stable 11 Fluorescence
Figure 11 DNA fragmentation and apoptotic population were suppressed in 7-4 derivatives expressing dominant negative raf-1. Cell maintenance and treatment were the same as described in Figure 9 . (A) DNA fragmentation analysis. (B) Quantification of apoptotic cells transfectants Ras 1, Ras 2 and Ras 3 with higher levels of dominant negative ras expression show lower AP-1 activity ( Figure  8A ), lower efficiency of colony formation ( Figure 8B ) and slower cell growth rate ( Figure 8C ) compared with the parental 7-4 cells, indicating that dominant-negative ras effectively blocked Ras activity. AP-consists of the members of the jun and the fos families, which can be activated by RAS; therefore, its activity can be used as the indicator of Ras activity. Moreover, the degree of DNA fragmentation and the population of apoptotic cells were all evidently decreased in these dominant-negative ras cell lines ( Figure 9A and B), indicating that ras indeed plays a major role in 7-4 cell apoptosis. Raf-1 is an effector of activated Ras and its downstream transducers are MAPK, Erk and Elk (Kauffmann-Zeh et al, 1997) . To unveil whether ras-triggered apoptosis is through the raf-l signalling pathway, the dominant negative raf-i gene (in plasmid pRafC4B, with a deletion at 3' end kinase domain) was transfected into 7-4 cells (Bruder et al, 1992) . Three cell lines Raf E, Raf F and Raf M stably expressing the raf-l gene were established (data not shown). To determine the activity of Raf-1, its downstream substrate Elk activity was measured by the PathDetect Elk-trans-reporter British Journal of Cancer (1998) Figure IOA and C) . Comparatively, Raf E showed much less efficiency in suppression of Raf activity, colony formation and cell growth. We found the mRNA level in Raf E cells is the lowest compared with the other two cells lines (data not shown). Correspondingly, the degree of DNA fragmentation and population of apoptotic cells in Raf F and Raf M were much lower than that in Raf E and 7-4 cells, indicating that the raf-l signalling pathway is indeed required for 7-4 cell apoptosis (Figure llA and B) .
DISCUSSION
It is conceivable that activated Ha-ras may alter the interactions between regulatory accessory factors such as Ras-GAP and Ras-GEF, thereby leading to deregulation of one or more members of the GTP-binding ras superfamily (Bokoch and Der, 1993) , such as ran/TC4 (Basu et al, 1992) . The product of ran/TC4 is necessary for the function of RCC 1, which is a gene product involved in coordinating the end of the S-phase and chromosome condensation (Ren et al, 1993) . It is also known that inappropriate expression of normal or activated ras can interfere with normal cell cycle progression (Feramisco et al, 1984; Mulcahy et al, 1985) . Denko et al (1994) have shown that selective induction of the activated Haras transgene with IPTG is sufflcient to disrupt at least one cell cycle control point by stimulating serum-deprived 212 cells to progress from GU arrest into S-phase. All the data indicate that activated ras can facilitate the transition from GI to S-phase of the cell cycle. This phenomenon is consistent with our observation of 7-4 cells that accumulated in S-phase while activated Ha-ras was overexpressed by IPTG.
The disruption of the normal cell cycle that resulted in the death of the cells has been reported (Rubin et al, 1993) . Meikrantz et al (1994) classified the death of S-phase-arrested cells in an asynchronous population into multiple forms of apoptosis. The correlation between S-phase arresting and apoptosis may explain that 7-4 cells with a major population of S-phase-arrested cells showed high mortality, significant DNA fragmentation and strong acridine orange staining. Such cell cycle disruption may result from either gene expression at the wrong time or aberrant expression of normal cell cycle kinases, including activation or inactivation (Rubin et al, 1993) . Chen and Pan (1994) reported that in Xenopus oocytes, Ha-ras oncogene overexpression suppressed the activity but not the expression level of p34cdc2, and subsequently led the cell to rest in M-phase. In our study, Ha-ras overexpression greatly suppressed p34cdc2 expression level and led the cells to accumulate in S-phase. Many factors may be involved in the process of Ha-ras-induced apoptosis, but the relationships largely remain unknown (Whyte and Evan, 1995) . The possible mechanisms of Ha-ras overexpression-induced apoptosis in 7-4 cells are as follows: (a) overexpression of Ha-ras oncogene inactivates cell cycle-related kinases (such as the kinase p34cdc2) (Girard et al, 1991) ; (b) Ha-ras overexpression shuts off the expression of 'survival' genes, such as bcl-2 in the absence of appropriate growth factors under serum depleted condition and guides cells to death; (c) the unknown factor that triggered the apoptotic pathway was specially activated in 7-4 cells (such as IRF-1) (Tanaka et al, 1994) . Overexpression of the bcl-2 gene blocked Ha-ras-induced apoptosis but had no effect on Ha-ras oncogene expression, indicating that its prevention of apoptosis is downstream in the Ha-ras signalling pathway (unpublished data). Moreover, Bcl-2 and p2lras molecules can be co-immunoprecipitated in Jurkat cells, and phosphorylation of the Bcl-2 protein is involved in the prevention of cell apoptosis (Chen and Faller, 1996) . However, the precise mechanism by which the bcl-2 gene prevents Ha-ras-induced apoptosis remains to be determined.
Our results from (a) selective overexpression of activated Haras oncogene by IPTG; and (b) specific blockage of Ras activity by dominant negative ras or dominant negative raf clearly demonstrate that overexpression of activated Ha-ras indeed induces 7-4 cells apoptosis under serum-deprived conditions. Activated Haras-induced apoptosis was also detected in the other transformant 212 cells. But the degree of apoptosis was less severe compared with 7-4 cells, indicating that factors other than Ha-ras activation may also be involved. However, our observation that 7-4 cells proceeded with apoptosis without c-myc overexpression (unpublished data) is different from Kauffmann-Zeh's report that both Ha-ras and c-myc are overexpressed in the apoptosis of the fibroblasts (Kauffmann-Zeh et al, 1997) . This contrasting result indicates that c-myc overexpression is not an inducing factor but an end-point response of Ha-ras-induced apoptosis.
The effect of serum starvation on long-term viability of the cells was observed by measuring the percentage of dye excluding cells that were stained with 0.04% trypan blue at a 24-h interval. We found that, 72 h after starvation, the percentage of viable 7-4 cells is 88% in the absence of IPTG and drops to 50% in the presence of IPTG compared with NIH/3T3 cells (100%), indicating that NIH/3T3 and 7-4 cells could stand long-term starvation (unpublished data). Ha-ras gene overexpression makes 7-4 cells more vulnerable to serum deprivation and induces them to apoptosis.
The uncertainty whether nutrient deficiency caused by serum starvation may induce cell apoptosis was clarified by growing the cells in the medium supplemented with 10% AC-2 (Valio, Finland; collostrum, a serum substitute). We found that NIH/3T3 and a lung carcinoma cell line H2981 could grow normally in this kind of medium (unpublished data). In contrast, 7-4 cells with Ha-ras overexpression maintained in the same conditions underwent apoptosis, indicating that serum depletion causing nutrient deficiency is not a determining factor of apoptosis. It is consistent with Kulkarni's report that serum starvation only caused minor cell apoptosis (Kulkarni and McCulloch, 1994) . The amount of certain growth factors such as IGF-I in either 0.2% serum or 10% AC-2 may be critical to determine cell survival or death. A detailed study is under way. Dominant negative raf-l blocked the Raf-1-MAPK pathway and prevented apoptosis of 7-4 cells, indicating that Ha-ras-induced apoptosis needs Raf-I -MAPK pathway activity, which is consistent with Kauffmann-Zeh's observation that Raf-l-MAPK is an apoptotic pathway. It seems that the Raf-MAPK pathway is a common pathway for both proliferation and apoptosis. We hypothesize that in NIH/3T3 fibroblasts while Ha-ras was overexpressed, serum starvation as an exogenous stress will turn on the apoptotic signal through British Journal of Cancer (1998) 77(11), [1777] [1778] [1779] [1780] [1781] [1782] [1783] [1784] [1785] [1786] Ha-ras and raf-1 signalling pathways. The fate of the cells will then be executed by downstream specific nuclear transactivators, which are formed after Ha-ras activation and activated through dimer formation (such as the pairing of the members ofjun and for families) that activate either survival genes or apoptotic genes. Ha-ras overexpression activated downstream from the expression of apoptotic-related genes was sustained by a protein synthesis inhibitor cycloheximide study, which delayed 7-4 cell apoptosis.
In conclusion, our study demonstrates that Ha-ras,,12 overexpression without c-myc overexpression can trigger cell apoptosis This apoptosis may use the Raf-l-MAPK pathway to synthesize specific nuclear factors and subsequently to turn on apoptotic-related genes. These events were confirmed by the studies of dominantnegative ras, raf-1, cycloheximide and bcl-2 gene overexpression.
The relationship between Ha-rasvaIl2 oncogene overexpression and cell apoptosis observed in our laboratory will shed light on the understanding of Ha-ras oncogene-related apoptosis and aid in unveiling the factors that lead tumour cells with the expression of activated Ha-ras oncogene to programmed cell death.
